prof. dr. Koen Van Laere
prof. dr. Koen Van Laere
Explore linked clinical trials.2 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Comparison of NeuroEXPLORER PET/CT Versus Standard-of-care PET/CT of the Head and Neck Region. | Head and Neck Neoplasms, Lewy body dementia, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, Nutritional and Metabolic Diseases, Parathyroid Neoplasms, Parkinson disease, Pituitary Neoplasms, TDP-43 proteinopathy, amyotrophic lateral sclerosis, basal ganglia disorder, brain cancer, brain disorder, central nervous system cancer, central nervous system disorder, cognitive disorder, dementia, endocrine system disorder, epilepsy, epithelial neoplasm, hypothalamic disorder, hypothalamic neoplasm, malignant endocrine neoplasm, metabolic disease, motor neuron disorder, movement disorder, neoplasm, nervous system disorder, neuroblastoma, neurodegenerative disease, neuroepithelial neoplasm, neuromuscular disease, parathyroid gland adenoma, parathyroid gland disorder, parkinsonian disorder, pituitary gland adenoma, pituitary gland disorder, primitive neuroectodermal tumor, proteostasis deficiencies, psychiatric disorder, spinal cord disorder, supratentorial cancer, synucleinopathy | Enrolling by invitation | Not applicable | 2026-05-19 | NCT07595666 | |
| [18F]-MFBG Versus [123I]-MIBG and [18F]-PE2I in PD vs. MSA and DLB vs. AD | Alzheimer disease, Lewy body dementia, Parkinson disease, autonomic nervous system disorder, basal ganglia disorder, brain disorder, cardiovascular disorder, central nervous system disorder, cognitive disorder, dementia, hypotensive disorder, movement disorder, multiple system atrophy, nervous system disorder, neurodegenerative disease, parkinsonian disorder, primary dysautonomia, psychiatric disorder, synucleinopathy, tauopathy, vascular disorder | Recruiting | Phase 2 / Phase 3 | 2025-02-06 | NCT06120049 |